PFIZER INC

0000001 - Document - Cover Page

0000002 - Document - Audit Information

9952151 - Statement - Consolidated Statements of Operations

9952152 - Statement - Consolidated Statements of Comprehensive Income

9952153 - Statement - Consolidated Balance Sheets

9952154 - Statement - Consolidated Balance Sheets (Parenthetical)

9952155 - Statement - Consolidated Statements of Equity

9952156 - Statement - Consolidated Statements of Equity (Parenthetical)

9952157 - Statement - Consolidated Statements of Cash Flows

9952158 - Disclosure - Basis of Presentation and Significant Accounting Policies

9952159 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements

9952160 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives

9952161 - Disclosure - Other (Income)/Deductions???Net

9952162 - Disclosure - Tax Matters

9952163 - Disclosure - Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests

9952164 - Disclosure - Financial Instruments

9952165 - Disclosure - Other Financial Information

9952166 - Disclosure - Property, Plant and Equipment, Net

9952167 - Disclosure - Identifiable Intangible Assets, Net and Goodwill

9952168 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans

9952169 - Disclosure - Equity

9952170 - Disclosure - Share-Based Payments

9952171 - Disclosure - Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders

9952172 - Disclosure - Leases

9952173 - Disclosure - Contingencies and Certain Commitments

9952174 - Disclosure - Segment, Geographic and Other Revenue Information

995445 - Disclosure - Insider Trading Arrangements

995447 - Disclosure - Insider Trading Policies and Procedures

995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure

9955511 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)

9955512 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables)

9955513 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements (Tables)

9955514 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives (Tables)

9955515 - Disclosure - Other (Income)/Deductions???Net (Tables)

9955516 - Disclosure - Tax Matters (Tables)

9955517 - Disclosure - Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests (Tables)

9955518 - Disclosure - Financial Instruments (Tables)

9955519 - Disclosure - Other Financial Information (Tables)

9955520 - Disclosure - Property, Plant and Equipment, Net (Tables)

9955521 - Disclosure - Identifiable Intangible Assets, Net and Goodwill (Tables)

9955522 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans (Tables)

9955523 - Disclosure - Share-Based Payments (Tables)

9955524 - Disclosure - Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)

9955525 - Disclosure - Leases (Tables)

9955526 - Disclosure - Segment, Geographic and Other Revenue Information (Tables)

9955527 - Disclosure - Basis of Presentation and Significant Accounting Policies - Narrative (Details)

9955528 - Disclosure - Basis of Presentation and Significant Accounting Policies - Accrued Rebates and Other Accruals (Details)

9955529 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Acquisitions (Details)

9955530 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Purchase Price Allocation (Details)

9955531 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Purchase Price Allocation - Footnotes (Details)

9955532 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Pro Forma Information (Details)

9955533 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Pro Forma Information - Footnotes (Details)

9955534 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Divestitures (Details)

9955535 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Change in the Carrying Value of Equity Method Investment (Details)

9955536 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Change in the Carrying Value of Equity Method Investment - Footnotes (Details)

9955537 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Summarized Financial Information of Equity Method Investee (Details)

9955538 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Equity Method Investments (Details)

9955539 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions (Details)

9955540 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Research and Development Arrangement (Details)

9955541 - Disclosure - Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - In-Licensing Arrangements (Details)

9955542 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Narrative (Detail)

9955543 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Costs (Detail)

9955544 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Costs - Footnotes (Detail)

9955545 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Restructuring Accruals (Detail)

9955546 - Disclosure - Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Restructuring Accruals - Footnotes (Detail)

9955547 - Disclosure - Other (Income)/Deductions???Net - Schedule of Other Nonoperating Income (Expense) (Details)

9955548 - Disclosure - Other (Income)/Deductions???Net - Schedule of Other Nonoperating Income (Expense) - Footnotes (Details)

9955549 - Disclosure - Other (Income)/Deductions???Net - Schedule of Additional Information About Intangible Assets Impaired (Details)

9955550 - Disclosure - Tax Matters - Income from Continuing Operations Before Provision for Taxes on Income (Details)

9955551 - Disclosure - Tax Matters - Provision for Taxes on Income (Details)

9955552 - Disclosure - Tax Matters - Narrative (Details)

9955553 - Disclosure - Tax Matters - Schedule of Cash Paid for Income Taxes, Net of Refunds (Details)

9955554 - Disclosure - Tax Matters - Tax Rate Reconciliation (Details)

9955555 - Disclosure - Tax Matters - Deferred Taxes (Details)

9955556 - Disclosure - Tax Matters - Deferred Taxes - Footnotes (Details)

9955557 - Disclosure - Tax Matters - Reconciliation of Gross Unrecognized Tax Benefits (Details)

9955558 - Disclosure - Tax Matters - Reconciliation of Gross Unrecognized Tax Benefits - Footnotes (Details)

9955559 - Disclosure - Tax Matters - Taxes on Items of Other Comprehensive Income/(Loss) (Details)

9955560 - Disclosure - Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests (Details)

9955561 - Disclosure - Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)

9955562 - Disclosure - Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis - Footnotes (Details)

9955563 - Disclosure - Financial Instruments - Schedule of Changes in Contingent Consideration Liabilities (Details)

9955564 - Disclosure - Financial Instruments - Assets and Liabilities Not Measured at Fair Value on a Recurring Basis (Details)

9955565 - Disclosure - Financial Instruments - Investments (Details)

9955566 - Disclosure - Financial Instruments - Investments - Debt Securities (Details)

9955567 - Disclosure - Financial Instruments - Investments - Unrealized Gains and Losses Related to Equity Securities (Details)

9955568 - Disclosure - Financial Instruments - Investments - Unrealized Gains and Losses Related to Equity Securities - Footnotes (Details)

9955569 - Disclosure - Financial Instruments - Short-Term Borrowings (Details)

9955570 - Disclosure - Financial Instruments - Short-Term Borrowings - Footnotes (Details)

9955571 - Disclosure - Financial Instruments - Long-Term Debt (Details)

9955572 - Disclosure - Financial Instruments - Long-Term Debt, New Issuances (Details)

9955573 - Disclosure - Financial Instruments - Derivative Financial Instruments and Hedging Activities- Narrative (Details)

9955574 - Disclosure - Financial Instruments - Fair Value of Derivative Financial Instruments and Related Notional Amounts (Details)

9955575 - Disclosure - Financial Instruments - Derivative Financial Instruments and Hedging Activities (Details)

9955576 - Disclosure - Financial Instruments - Derivative Financial Instruments and Hedging Activities - Footnotes (Details)

9955577 - Disclosure - Financial Instruments - Cumulative Basis Adjustments for Fair Value Hedges (Details)

9955578 - Disclosure - Financial Instruments - Credit Risk (Details)

9955579 - Disclosure - Other Financial Information - Inventories (Details)

9955580 - Disclosure - Other Financial Information - Other Current Liabilities (Details)

9955581 - Disclosure - Other Financial Information - Supplier Finance Program Obligation (Details)

9955582 - Disclosure - Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)

9955583 - Disclosure - Property, Plant and Equipment - Long-lived Assets by Geographic Areas, Net (Details)

9955584 - Disclosure - Identifiable Intangible Assets, Net and Goodwill - Finite-lived and Indefinite-lived Intangible Assets (Details)

9955585 - Disclosure - Identifiable Intangible Assets, Net and Goodwill - Finite-lived and Indefinite-lived Intangible Assets - Footnotes (Details)

9955586 - Disclosure - Identifiable Intangible Assets, Net and Goodwill - Narrative (Details)

9955587 - Disclosure - Identifiable Intangible Assets, Net and Goodwill - Expected Annual Amortization Expense (Details)

9955588 - Disclosure - Identifiable Intangible Assets, Net and Goodwill - Goodwill (Details)

9955589 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Schedule of Net Periodic Benefit Costs (Details)

9955590 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Weighted-Average Actuarial Assumptions (Details)

9955591 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Healthcare Cost Trend Rate Assumptions (Details)

9955592 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Obligations and Funded Status (Details)

9955593 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Plan Assets (Details)

9955594 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Long-term Target Asset Allocations Ranges and the Percentage of the Fair Value of Plan Assets (Detail)

9955595 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Analysis of Changes in Significant Investments Valued Using Significant Unobservable Inputs (Details)

9955596 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Expected Future Cash Flow Information (Details)

9955597 - Disclosure - Pension and Postretirement Benefit Plans and Defined Contribution Plans - Narrative (Details)

9955598 - Disclosure - Equity (Details)

9955599 - Disclosure - Share-Based Payments - Narrative (Detail)

9955600 - Disclosure - Share-Based Payments - Schedule of Share-based Compensation Awards and Valuation Details (Details)

9955601 - Disclosure - Share-Based Payments - Summary of Data Related to Share-based Payment Arrangement Activity (Details)

9955602 - Disclosure - Share-Based Payments - Schedule of Valuation Assumptions (Detail)

9955603 - Disclosure - Share-Based Payments - Schedule of Share-based Payment Arrangement Activity (Detail)

9955604 - Disclosure - Share-Based Payments - Summary of TSRU and PTU Activity (Details)

9955605 - Disclosure - Share-Based Payments - Schedule of Share-based Compensation, Stock Options, Activity (Detail)

9955606 - Disclosure - Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Details)

9955607 - Disclosure - Leases - Narrative (Details)

9955608 - Disclosure - Leases - Schedule of Lease Assets and Liabilities (Details)

9955609 - Disclosure - Leases - Schedule of Lease Costs and Other Supplemental Information (Details)

9955610 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Detail)

9955611 - Disclosure - Contingencies and Certain Commitments - Patent Litigation (Details)

9955612 - Disclosure - Contingencies and Certain Commitments - Legal Proceedings-Government Investigations (Details)

9955613 - Disclosure - Contingencies and Certain Commitments - Certain Commitments and Contingent Consideration for Acquisitions (Details)

9955614 - Disclosure - Segment, Geographic and Other Revenue Information - Narrative (Detail)

9955615 - Disclosure - Segment, Geographic and Other Revenue Information - Schedule of Segment Reporting Information by Segment (Details)

9955616 - Disclosure - Segment, Geographic and Other Revenue Information - Schedule of Significant Biopharma Segment Expenses (Details)

9955617 - Disclosure - Segment, Geographic and Other Revenue Information - Revenues by Geographic Area (Detail)

9955618 - Disclosure - Segment, Geographic and Other Revenue Information - Schedules of Concentration of Risk (Details)

9955619 - Disclosure - Segment, Geographic and Other Revenue Information - Revenues by Product (Detail)

9955620 - Disclosure - Segment, Geographic and Other Revenue Information - Revenues by Product - Footnotes (Details)